Turn Diagnostic Intelligence into Timely, Targeted HCP Engagement

Your guide to moving beyond claims-led targeting

Traditional claims-led targeting can show where activity has already occurred, but it may not provide a complete view of the patient’s disease experience, therapy-relevant diagnostic events as they emerge, or the HCP currently managing the patient.

Diagnostic results offer a different starting point. By identifying therapy-relevant diagnostic events and connecting them to treating HCPs, diagnostic intelligence can help teams focus engagement around active patient need while treatment decisions are still being shaped.

TREATMENT DECISIONS BEGIN WITH LAB TEST RESULTS. BE THERE WHEN IT HAPPENS.

Diaceutics diagnostic intelligence delivers clinically relevant HCP engagement opportunities built from real-time laboratory data instead of the lagging indicators found in retrospective claims. By connecting lab data like biomarker results, testing signals, and treatment decision timing directly to treating physicians, pharmaceutical marketers can engage clinicians at the moment clinical decisions are actively being made for eligible patients.

0163_Fierce Pharma Sales Sheet_V1

Precision Targeting Matched to the Clinical Moment

0163_Fierce Pharma Sales Sheet_V1
600 +
U.S. LABORATORY PARTNERS
100
READY TO ACTIVATE HCP AUDIENCES
% 70
Of treatment decisions influenced by lab results*

OUR ENGAGEMENT SOLUTIONS

Connect diagnostic intelligence with timely HCP engagement, expert-developed education, and trusted diagnostic expertise.

SIGNAL

Text explaining

Physician Engage

Text explaining

Expert Exchange

Text explaining

SIGNAL

Text explaining
Download PDF
Diaceutics_SIGNAL_Fact_Sheet_Final

Physician Engage

Text explaining
Download PDF
Diaceutics_Physician_Engage_Fact_Sheet_Final (1)-1

Expert Exchange

Text explaining
Download PDF
Diaceutics_EXPERT EXCHANGE_Fact_Sheet_Final-1
See diagnostic-led engagement in action
7 x
Return on investment
300 +
unique providers identified
2,300 +
therapy eligible patients
The Challenge

The client needed to identify and engage HCPs managing newly diagnosed patients with myeloid malignancies and anemia in real time. Myeloid malignancies are complex diseases, and 40% of patients present with moderate to severe anemia at diagnosis. Timely identification and engagement were critical to support appropriate treatment decisions and improve patient outcomes.


Our Approach

Diaceutics implemented Physician Engage, using real-world, multimodal data to identify HCPs managing patients newly diagnosed with myeloid malignancies. The strategy included:

  • Daily lab alerts to identify relevant HCPs
  • Omnichannel engagement through email and banner advertising
  • Personalized educational content delivered within 24 hours
  • Real-time tracking of engagement metrics
  • NPI-level targeting focused on opportunities to influence behavior

Collaboration Model:

An agile, data-driven program co-created with the client over 6 months.

Business-Critical Issues

  • Delayed treatment decisions due to lack of timely HCP identification
  • Limited therapy awareness among HCPs
  • Potential loss of revenue and missed opportunities for therapy adoption
  • Complexity of diagnosing myeloid malignancies
  • Need for real-world evidence (RWE) to support HCP targeting
  • Increasing demand for precision health approaches

 

External Factors

  • Complexity of diagnosing myeloid malignancies
  • Need for real-world evidence (RWE) to support HCP targeting
  • Increasing demand for precision health approaches

Results & Impact

  • The program identified 2,398 patients and engaged 384 HCPs
  • The program delivered a 7X return on investment

 

Why It Matters

When treatment decisions move quickly, delayed HCP identification can mean missed opportunities for both patients and your brand. Physician Engage helps you identify relevant HCPs and deliver targeted education within 24 hours, giving your teams the opportunity to act earlier, build therapy awareness and support more timely treatment decisions. In this program, that approach identified 2,398 patients, engaged 384 HCPs and delivered a 7x return on investment.

 

Testimonial

"Our customer reported that Physician Engage changed HCP behavior and increased treatment prescriptions."

Diaceutics Product Ecosystem Diagram Updated 110826

Turn diagnostic activity into earlier insight, smarter engagement and a clearer path to the right therapy

The dynamic product ecosystem designed for dx-driven therapies.

Diagnostic-driven therapies move too fast for siloed data, static targeting and retrospective planning.

Powered by Diaceutics Reveal, our solutions connect real-world diagnostic activity with the intelligence and engagement your teams need to act sooner.

Use Intelligence Solutions to see where diagnostic activity is creating opportunity - where patients are being missed, which HCPs shape care, and which labs can change the pathway.

Engagement Solutions help your teams reach the people who can move that pathway forward—through targeted HCP marketing, scientific exchange and lab engagement at the moment that matters.

Together, they help you move earlier, focus smarter and keep adoption moving.

Diaceutics Product Ecosystem Diagram Updated 110826

 TURN DIAGNOSTIC RESULTS INTO TIMELY, TARGETED HCP ENGAGEMENT  

 Ready to move beyond historical claims? 

Talk to our team today 

Share:

You might also be interested in?